Improving Care for Patients with Hypertrophic Cardiomyopathy

This document is a project report detailing a collaborative working initiative between Bristol-Myers Squibb Pharmaceutical Limited and Guy’s and St Thomas’ Hospitals NHS Foundation Trust. The project aims to enhance care for patients with Hypertrophic Cardiomyopathy (HCM) and left ventricular outflow tract obstruction (LVOTO) by integrating digital solutions and establishing a Clinical Scientist-led LVOTO clinic. The report outlines the project’s objectives, which include the efficient identification of patients through data mining technology and improved communication between patients and healthcare providers. The initiative seeks to address the backlog of work exacerbated by the COVID-19 pandemic and improve access to specialist care. Additionally, the project aims to share best practices nationally, evaluate digital technology initiatives, and provide insights into healthcare outcomes, particularly focusing on health inequalities. The document also discusses the anticipated benefits for patients, BMS, and the NHS, as well as the financial arrangements and project timelines.